CRI
AZN icon

Commonwealth Retirement Investments’s AstraZeneca AZN Stock Holding History

Commonwealth Retirement Investments’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.91K Buy
+47
New +$8.84K ﹤0.01% 315
2026
Q1 		– Sell
-47
Closed -$8.64K – 145
2025
Q4 		$8.64K Buy
+47
New +$8.24K ﹤0.01% 332

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Commonwealth Retirement Investments's AZN Position: Q2 2026 in Review

Commonwealth Retirement Investments opened a new position in AstraZeneca (AZN) in Q2 2026: 47 shares worth $8.91K. The stake represents ﹤0.01% of the portfolio and ranks #315 among its holdings. This is a return to the name: Commonwealth Retirement Investments previously reported a position in AZN as recently as Q4 2025.

Commonwealth Retirement Investments first reported a position in AZN in Q4 2025 and has held it in 2 quarters since. 1,507 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Commonwealth Retirement Investments held 47 shares of AstraZeneca worth $8.91K as of Q2 2026.
  • AstraZeneca was a new Commonwealth Retirement Investments position in Q2 2026.
  • AstraZeneca made up ﹤0.01% of Commonwealth Retirement Investments's portfolio in Q2 2026, its #315 holding.
  • Commonwealth Retirement Investments first reported a position in AstraZeneca in Q4 2025 and has held it in 2 quarters since.
  • 1,507 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Commonwealth Retirement Investments's 13F filing for Q2 2026, filed 3 Aug 2026.